Dr. Tania Fernandez , Director, Burrill & Company added, "Our investment in Strand Life Sciences reflects our continued commitment to the life science sector in India. We constantly analyze the Indian life science landscape, in search of leading edge platform technologies and products, helping companies develop these to full potential and expanding their access to global markets. Strand is a leading-edge bioinformatics company developing healthcare applications. We intend to work with Strand to help them build a preeminent position globally in what we consider the future of medicine: next-generation sequencing (NGS) and its applications in healthcare."
About Strand Life Sciences Pvt. Ltd.
Strand Life Sciences - "Strand" - has pioneered the practice of data science in life and health sciences. Strand's segue into the life sciences was through informatics products and services for research biologists, chemists, and toxicologists that combine advanced visualization, predictive systems modeling, data integration and scientific content management. Over 2000 research laboratories worldwide (about 30% of global market share) are licensees of Strand's technology products as are several leading pharmaceutical and biotechnology companies. Strand and its partner Ganit Labs share additional 10,000 square feet of laboratory space with state of the art clinical genomics capabilities and capacity for pre-clinical toxicology assays of lead compounds.
About Burrill & Co.
Founded in 1994, Burrill & Company is a diversified global financial services firm focused on the life
|SOURCE Strand Life Sciences |
Copyright©2012 PR Newswire.
All rights reserved